Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

Abstract

Reactive oxygen species (ROS) are emerging as key effectors in signal transduction. This role of ROS is especially evident in the pathways leading to programmed cell death (PCD) elicited in response to certain stress stimuli and cytokines. In these pathways, cytotoxic ROS signaling appears to be mediated in part by activation of the c-Jun-N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) cascade. Another pathway that is under ROS-mediated control in some systems is that leading to activation of transcription factor nuclear factor-kappa B (NF-κB), which is a central regulator of immunity, inflammation and cell survival. Remarkably, new evidence has unveiled the existence of a reciprocal, negative control that NF-κB exerts on ROS and JNK activities. This NF-κB-imposed restraint on ROS and JNK signaling is crucial for antagonism of PCD elicited by the proinflammatory cytokine tumor necrosis factor (TNF)α and likely other triggers. Effectors of this antagonistic cross-talk between NF-κB and ROS/JNK pathways have recently been identified. Because of the key roles that the prosurvival function of NF-κB plays in organismal physiology and disease, gaining a further mechanistic understanding of this cross-talk and NF-κB-dependent survival may be key to developing new therapies for the treatment of widespread human illnesses, such as cancer and chronic inflammatory conditions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abe J, Okuda M, Huang Q, Yoshizumi M, Berk BC . (2000). J Biol Chem 275: 1739–1748.

  • Aggarwal BB . (2003). Nat Rev Immunol 3: 745–756.

  • Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M et al. (2001). J Immunol 167: 1592–1600.

  • Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K et al. (2001). Hypertension 38: 48–55.

  • Arosio P, Levi S . (2002). Free Radical Biol Med 33: 457–463.

  • Baeuerle PA, Henkel T . (1994). Annu Rev Immunol 12: 141–179.

  • Balaban RS, Nemoto S, Finkel T . (2005). Cell 120: 483–495.

  • Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D . (1995). Nature 376: 167–170.

  • Belich MP, Salmeron A, Johnston LH, Ley SC . (1999). Nature 397: 363–368.

  • Benhar M, Engelberg D, Levitzki A . (2002). EMBO Rep 3: 420–425.

  • Beraud C, Henzel WJ, Baeuerle PA . (1999). Proc Natl Acad Sci USA 96: 429–434.

  • Bernard D, Quatannens B, Begue A, Vandenbunder B, Abbadie C . (2001). Cancer Res 61: 2656–2664.

  • Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP, Bours V . (1996). Eur J Biochem 242: 544–549.

  • Bonizzi G, Piette J, Merville MP, Bours V . (2000). Biochem Pharmacol 59: 7–11.

  • Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP et al. (1999). Mol Cell Biol 19: 1950–1960.

  • Bottero V, Withoff S, Verma IM . (2006). Cell Death Differ 13: 785–797.

  • Bowie A, Moynagh PN, O'Neill LA . (1997). J Biol Chem 272: 25941–25950.

  • Bowie A, O'Neill LA . (2000). Biochem Pharmacol 59: 13–23.

  • Brasseres D, Baldwin Jr AS . (2006). Oncogene 25: 6817–6830.

  • Brennan P, O'Neill LA . (1995). Biochim Biophys Acta 1260: 167–175.

  • Brennan P, O'Neill LA . (1996). Biochem J 320: 975–981.

  • Brigelius-Flohe R, Banning A, Kny M, Bol GF . (2004). Arch Biochem Biophys 423: 66–73.

  • Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P . (2003). Nat Immunol 4: 387–393.

  • Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al. (2006). Cell 124: 601–613.

  • Chen F, Castranova V, Li Z, Karin M, Shi X . (2003). Cancer Res 63: 7689–7693.

  • Chen F, Shi X . (2002). Environ Health Perspect 110: 807–811.

  • Claudio E, Brown K, Siebenlist U . (2006). Cell Death Differ 13: 697–701.

  • Courtois G, Smahi A . (2006). Cell Death Differ 13: 843–851.

  • Curtin JF, Donovan M, Cotter TG . (2002). J Immunol Methods 265: 49–72.

  • Danial NN, Korsmeyer SJ . (2004). Cell 116: 205–219.

  • Davis RJ . (2000). Cell 103: 239–252.

  • De Bosscher K, Vanden Berghe W, Haegeman G . (2006). Oncogene 25: 6868–6886.

  • De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al. (2001). Nature 414: 308–313.

  • Delhalle S, Deregowski V, Benoit V, Merville MP, Bours V . (2002). Oncogene 21: 3917–3924.

  • Deng Y, Ren X, Yang L, Lin Y, Wu X . (2003). Cell 115: 61–70.

  • Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ et al. (1999). Proc Natl Acad Sci USA 96: 2994–2999.

  • Dutta J, Fan, Gupta N, Fan G, Gélinas C . (2006). Oncogene 25: 6800–6816.

  • Edinger AL, Thompson CB . (2004). Curr Opin Cell Biol 16: 663–669.

  • Fiers W, Beyaert R, Declercq W, Vandenabeele P . (1999). Oncogene 18: 7719–7730.

  • Flohe L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L . (1997). Free Radical Biol Med 22: 1115–1126.

  • Franzoso G, Zazzeroni F, Papa S . (2003). Cell Death Differ 10: 13–15.

  • Garg AK, Aggarwal BB . (2002). Mol Immunol 39: 509–517.

  • Gerondakis, Strasser . (2003). Semin Immunol 15: 159–166.

  • Ghoda L, Lin X, Greene WC . (1997). J Biol Chem 272: 21281–21288.

  • Gilmore TD . (2003). Cancer Treat Res 115: 241–265.

  • Gilmore TD . (2006). Oncogene 25: 6680–6684.

  • Gilmore TD and Herscovitch M . (2006). Oncogene 25: 6887–6899.

  • Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C et al. (2005). Cell 122: 221–233.

  • Gloire G, Legrand-Poels S, Piette J . (2006). Biochem Pharmacol, in press.

  • Greten FR, Karin M . (2004). Cancer Lett 206: 193–199.

  • Griffith CE, Zhang W, Wange RL . (1998). J Biol Chem 273: 10771–10776.

  • Haddad JJ . (2002). Cell Signal 14: 879–897.

  • Hammerman PS, Fox CJ, Thompson CB . (2004). Trends Biochem Sci 29: 586–592.

  • Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H et al. (2003). EMBO J 22: 3356–3366.

  • Hayashi T, Ueno Y, Okamoto T . (1993). J Biol Chem 268: 11380–11388.

  • Hayden MS, Ghosh S . (2004). Genes Dev 18: 2195–2224.

  • Hentze MW, Muckenthaler MU, Andrews NC . (2004). Cell 117: 285–297.

  • Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, Yodoi J . (1999). J Biol Chen 274: 27891–27897.

  • Hirota K, Murata M, Itoh T, Yodoi J, Fukuda K . (2001). FEBS Lett 489: 134–138.

  • Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S et al. (2000). Nat Immunol 1: 489–495.

  • Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C et al. (1996). Cell 86: 787–798.

  • Jäättelä M, Tschopp J . (2003). Nat Immunol 4: 416–423.

  • Janssen-Heininger YM, Poynter ME, Baeuerle PA . (2000). Free Radical Biol Med 28: 1317–1327.

  • Jaspers I, Zhang W, Fraser A, Samet JM, Reed W . (2001). Am J Respir Cell Mol Biol 24: 769–777.

  • Jin DY, Chae HZ, Rhee SG, Jeang KT . (1997). J Biol Chem 272: 30952–30961.

  • Kabe Y, Ando K, Hirao S, Yoshida M, Handa H . (2005). Antioxidant Redox Signal 7: 395–403.

  • Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M . (2005). Cell 120: 649–661.

  • Kapahi P, Takahashi T, Natoli G, Adams SR, Chen Y, Tsien RY et al. (2000). J Biol Chem 275: 36062–36066.

  • Karin M . (2006). Nature 441: 431–436.

  • Karin M, Gallagher E . (2005). IUBMB Life 57: 283–295.

  • Karin M, Yamamoto Y, Wang QM . (2004). Nat Rev Drug Discov 1: 17–26.

  • Kennedy NJ, Davis RJ . (2003). Cell Cycle 2: 199–201.

  • Kim HJ, Hawke N, Baldwin AS . (2006). Cell Death Differ 13: 738–747.

  • Korn SH, Wouters EF, Vos N, Janssen-Heininger YM . (2001). J Biol Chem 276: 35693–35700.

  • Kretz-Remy C, Mehlen P, Mirault ME, Arrigo AP . (1996). J Cell Biol 133: 1083–1093.

  • Kucharczak J, Simmons MJ, Fan Y, Gélinas C . (2003). Oncogene 56: 8961–8982.

  • Kumar A, Takada Y, Boriek AM, Aggarwal BB . (2004). J Mol Med 82: 434–448.

  • Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ . (2003). Mol Cell 11: 1479–1489.

  • Lambeth JD . (2004). Nat Rev Immunol 4: 181–189.

  • Lee C, Lee SM, Mukhopadhyay P, Kim SJ, Lee SC, Ahn W-C et al. (2004). Nat Struct Biol 11: 1179–1185.

  • Leist M, Jäättelä M . (2001). Nat Rev Mol Cell Biol 2: 589–598.

  • Li N, Karin M . (1999). FASEB J 13: 1137–1143.

  • Liu CY, Takemasa A, Liles WC, Goodman RB, Jonas M, Rosen H et al. (2003). Blood 101: 295–304.

  • Livolsi A, Busuttil V, Imbert V, Abraham RT, Peyron JF . (2001). Eur J Biochem 268: 1508–1515.

  • Luo Y, Hattori A, Munoz J, Qin ZH, Roth GS . (1999). Mol Pharmacol 56: 254–264.

  • Maeda S, Chang L, Li ZW, Luo JL, Leffert H, Karin M . (2003). Immunity 19: 725–737.

  • Maeda S, Kamata H, Luo JL, Leffert H, Karin M . (2005). Cell 121: 977–990.

  • Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB . (1998). J Biol Chem 273: 13245–13254.

  • Marshall HE, Merchant K, Stamler JS . (2000). FASEB J 14: 1889–1900.

  • Martindale JL, Holbrook NJ . (2002). J Cell Physiol 192: 1–15.

  • Matsuzawa A, Ichijo H . (2005). Antioxidant Redox Signal 7: 472–481.

  • Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT . (1992). Nucleic Acids Res 20: 3821–3830.

  • Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K . (1997). J Neurosci Res 49: 681–697.

  • Mattson MP, Meffert MK . (2006). Cell Death Differ 13: 852–860.

  • Micheau O, Tschopp J . (2003). Cell 114: 181–190.

  • Michiels C, Minet E, Mottet D, Raes M . (2002). Free Radical Biol Med 33: 1231–1242.

  • Molitor JA, Ballard DW, Greene WC . (1991). New Biol 3: 987–996.

  • Moynagh PN, Williams DC, O'Neill LA . (1994). J Immunol 153: 2681–2690.

  • Mukhopadhyay A, Manna SK, Aggarwal BB . (2000). J Biol Chem 275: 8549–8555.

  • Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K . (2006). Cell Death Differ 13: 730–737.

  • Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M et al. (2002). J Biol Chem 277: 44548–44556.

  • Nobel CI, Kimland M, Lind B, Orrenius S, Slater AF . (1995). J Biol Chem 270: 26202–26208.

  • O'Neill LA . (2006). Curr Opin Immunol 18: 3–9.

  • Obin M, Shang F, Gong X, Handelman G, Blumberg J, Taylor A . (1998). FASEB J 12: 561–569.

  • O'Donnell VB, Spycher S, Azzi A . (1995). Biochem J 310: 133–141.

  • Orlowski RZ, Baldwin Jr AS . (2002). Trends Mol Med 8: 385–389.

  • Pahl HL . (1999). Oncogene 65: 704–708.

  • Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR et al. (2006). Cell Death Differ 13: 712–729.

  • Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S et al. (2004). Nat Cell Biol 2: 146–153.

  • Perkins ND . (2006). Oncogene 25: 6717–6730.

  • Perkins ND, Gilmore TD . (2006). Cell Death Differ 13: 759–772.

  • Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K et al. (2004). Cell 119: 529–542.

  • Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. (2004). Nature 431: 461–466.

  • Qin J, Clore GM, Kennedy WM, Huth JR, Gronenborn AM . (1995). Structure 3: 289–297.

  • Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N et al. (2004). Cell 117: 773–786.

  • Royall JA, Gwin PD, Parks DA, Freeman BA . (1992). Arch Biochem Biophys 294: 686–694.

  • Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y et al. (2003). EMBO J 22: 3898–3909.

  • Sasazuki T, Okazaki T, Tada K, Sakon-Komazawa S, Katano M, Tanaka M et al. (2004). Mol Immunol 41: 547–551.

  • Sauer H, Wartenberg M, Hescheler J . (2001). Cell Physiol Biochem 11: 173–186.

  • Scheidereit C . (2006). Oncogene 25: 6685–6705.

  • Schieven GL, Mittler RS, Nadler SG, Kirihara JM, Bolen JB, Kanner SB et al. (1994). J Biol Chem 269: 20718–20726.

  • Schmidt KN, Traenckner EB, Meier B, Baeuerle PA . (1995). J Biol Chem 270: 27136–27142.

  • Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J et al. (2004). Immunity 21: 415–428.

  • Schoonbroodt S, Ferreira V, Best-Belpomme M, Boelaert JR, Legrand-Poels S, Korner M et al. (2000). J Immunol 164: 4292–4300.

  • Schoonbroodt S, Piette J . (2000). Biochem Pharmacol 60: 1075–1083.

  • Schreck R, Albermann K, Baeuerle PA . (1992a). Free Radical Res Commun 17: 221–237.

  • Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA . (1992b). J Exp Med 175: 1181–1194.

  • Schreck R, Rieber P, Baeuerle PA . (1991). Embo J 10: 2247–2258.

  • Schwabe RF, Brenner DA . (2006). Am J Physiol Gastrointest Liver Physiol 290: 583–589.

  • Shou Y, Gunasekar PG, Borowitz JL, Isom GE . (2000). Toxicol Appl Pharmacol 164: 196–205.

  • Shrivastava A, Aggarwal BB . (1999). Antioxidant Redox Signal 1: 181–191.

  • Spiegelman VS, Stavropoulos P, Latres E, Pagano M, Ronai Z, Slaga TJ et al. (2001). J Biol Chem 276: 27152–27158.

  • Storz P . (2006). Sci STKE 332: re3.

  • Suzuki YJ, Mizuno M, Packer L . (1995). Biochem Biophys Res Commun 210: 537–541.

  • Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M et al. (2001). Nature 414: 313–317.

  • Thannickal VJ, Fanburg BL . (2000). Am J Physiol Lung Cell Mol Physiol 279: L1005–L1028.

  • Toledano MB, Leonard WJ . (1991). Proc Natl Acad Sci USA 88: 4328–4332.

  • Torti FM, Torti SV . (2002). Blood 99: 3505–3516.

  • Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A et al. (2000). Science 288: 870–874.

  • Traenckner EB, Wilk S, Baeuerle PA . (1994). EMBO J 13: 5433–5441.

  • Vanden Berghe T, Kalai M, van Loo G, Declercq W, Vandenabeele P . (2003). J Biol Chem 278: 5622–5629.

  • Ventura JJ, Cogswell P, Flavell RA, Baldwin Jr AS, Davis RJ . (2004). Genes Dev 18: 2905–2915.

  • Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W et al. (1998). J Exp Med 188: 919–930.

  • Victor VM, Rocha M, De la Fuente M . (2004). Int Immunopharmacol 4: 327–347.

  • Vollgraf U, Wegner M, Richter-Landsberg C . (1999). J Neurochem 73: 2501–2509.

  • Vulcano M, Meiss RP, Isturiz MA . (2000). Int J Immunopharmacol 2: 635–644.

  • Wajant H, Pfizenmaier K, Scheurich P . (2003). Cell Death Differ 10: 45–65.

  • Weil R, Israël A . (2006). Cell Death Differ 13: 826–833.

  • Wood MJ, Storz G, Tjandra N . (2004). Nature 430: 917–921.

  • Xie C, Zhang N, Zhou H, Li J, Li Q, Zarubin T et al. (2005). Mol Cell Biol 25: 6673–6681.

  • Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ et al. (1997). Nature 389: 865–870.

  • Zhang J, Johnston G, Stebler B, Keller ET . (2001). Antioxid Redox Signal 3: 493–504.

  • Zhang Y, Chen F . (2004). Cancer Res 64: 1902–1905.

  • Zhang JY, Green CL, Tao S, Khavari PA . (2004). Genes Dev 18: 17–22.

Download references

Acknowledgements

This research was supported in part by NIH Grants R01-CA84040 and R01-CA098583.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Franzoso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bubici, C., Papa, S., Dean, K. et al. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25, 6731–6748 (2006). https://doi.org/10.1038/sj.onc.1209936

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209936

Keywords

This article is cited by

Search

Quick links